Curebase was named a finalist in the CNS Summit Innovation Showcase.
Published
Signal category
Presence & Recognition
Quote
“Curebase has been named a finalist in the CNS Summit Innovation Showcase!”
— Curebase team
Company
Curebase
AI-native eClinical platform: modern recruitment tech, eConsent, eCOA, EDC, participant engagement, and site software.
- Industry
- Software Development
- Location
- San Francisco, US
- Company size
- 55 employees
Curebase is reimagining clinical research by building the AI-native eClinical platform that serves sponsors and sites on a single unified system, giving sites modern technology, sponsors pristine data, and ultimately supporting the acceleration of breakthrough treatments for patients. Our platform spans advanced patient recruitment technology, eConsent, eCOA/ePRO, electronic data capture (EDC), modern participant engagement, and site software. All powered by thoughtful AI woven throughout the system. With Sitebase, we offer free eSource, CTMS, eISF, and payment technology to clinical research sites, giving them access to the same cutting-edge tools larger organizations use, without worrying about cost. We're solving a fundamental industry imbalance: research sites deserve modern technology without financial barriers, and sponsors deserve pristine data quality that comes from tech that sites and patients actually like to use. When sites have technology they actually enjoy using, everyone wins: sponsors get complete, error-free data, sites can focus on patient care, and patients get better clinical trial experiences that bring breakthrough treatments to market faster. Research. Reimagined.
Founded 2017